Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Return on Sales: 2012-2025

Historic Return on Sales for Iovance Biotherapeutics (IOVA) over the last 2 years, with Sep 2025 value amounting to -1.59%.

  • Iovance Biotherapeutics' Return on Sales rose 292.00% to -1.59% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.59%, marking a year-over-year increase of 292.00%. This contributed to the annual value of -2.27% for FY2024, which is 37117.00% up from last year.
  • As of Q3 2025, Iovance Biotherapeutics' Return on Sales stood at -1.59%, which was up 1.65% from -1.61% recorded in Q2 2025.
  • Iovance Biotherapeutics' Return on Sales' 5-year high stood at -1.59% during Q3 2025, with a 5-year trough of -776.93% in Q3 2023.
  • Its 3-year average for Return on Sales is -161.81%, with a median of -4.51% in 2024.
  • Data for Iovance Biotherapeutics' Return on Sales shows a peak YoY skyrocketed of 77,241bps (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Iovance Biotherapeutics' Return on Sales stood at -418.04% in 2023, then spiked by 41,577bps to -2.27% in 2024, then skyrocketed by 292bps to -1.59% in 2025.
  • Its Return on Sales stands at -1.59% for Q3 2025, versus -1.61% for Q2 2025 and -1.76% for Q1 2025.